This study is for adults with multiple myeloma, a type of blood cancer. The researchers are exploring a new drug called linvoseltamab combined with other cancer treatments. Linvoseltamab has been tested before alone and helped some patients, but now scientists want to see if it works better with other drugs. The main aim is to find out if it is safe to use together with other treatments and to decide the best dose to use.

Key Points:

• The study will find out if linvoseltamab can improve multiple myeloma when given with other drugs.
• Participants will be checked for any side effects and how their body reacts to the new treatment.
• Eligibility includes having tried several other treatments before, and there are specific rules about past treatments.

For those considering joining, it's important to know this is about testing safety and effectiveness, and it may involve some risks. Participants will need to meet certain health criteria and previous treatment conditions to join the study.